Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Director/PDMR Shareholding

4 Jan 2022 09:27

RNS Number : 3367X
IQ-AI Limited
04 January 2022
Β 

4 January 2022

IQ-AI Ltd

("IQ-AI" or the "Company")

Β 

Director/PDMR Shareholding

Β 

IQ-AI announces that Michael Schmainda, Director of IQAI and CEO of Imaging Biometrics, has been granted an option to subscribe for 5,969,792 ordinary shares of 1p each in the Company ("Ordinary Shares") at an exercise price of 5.88p per share. The option will vest on 15 December 2024.

Β 

Michael Schmainda is currently interested in 9,108,400 Ordinary Shares, representing 4.99 per cent. of the voting rights of the Company.

Β 

The Directors of the Company accept responsibility for the contents of this announcement

Β 

-ENDS-

Β 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Brett Skelly/Vinod Kaushal

Tel: 020 7469 0930

Β 

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Schmainda

2

Reason for the notification

a)

Position/status

Director of the Company

b)

Initial notification /Amendment

Β 

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQ-AI Limited

b)

LEI

213800SPW48XRJS2QH57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

Β 

Β 

Β 

Β 

Β 

ISIN: JE00BD4H0R42

b)

Nature of the transaction

Grant of Option

Β 

c)

Price(s) and volume(s)

5,969,792 ordinary shares at 5.88p per share

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

N/A (single transaction)

Β 

e)

Date of the transaction

15 December 2021

Β 

f)

Place of the transaction

N/A

Β 

Β 

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEANFLEADAEEA
Date   Source Headline
22nd Jan 20077:02 amRNSTrading Statement
19th Jan 20072:45 pmRNSHolding(s) in Company
15th Jan 20071:41 pmRNSHolding(s) in Company
13th Dec 200612:19 pmRNSTotal Voting Rights
29th Nov 20069:01 amRNSShareholder & Board Change
18th Oct 20062:16 pmRNSHolding(s) in Company
16th Oct 200611:49 amRNSHolding(s) in Company
26th Sep 200610:31 amRNSBlocklisting Interim Review
21st Sep 200610:12 amRNSHolding(s) in Company
18th Sep 20067:01 amRNSAcquisition
10th Aug 200610:19 amRNSHolding(s) in Company
8th Aug 20067:01 amRNSTransaction in Own Shares
28th Jul 20067:01 amRNSInterim Results
18th Jul 20067:00 amRNSNotice of Interim Results
27th Jun 20064:52 pmRNSChange of Auditors
3rd May 20065:09 pmRNSDirectorate Change
28th Apr 20067:01 amRNSHolding(s) in Company
13th Apr 200610:15 amRNSAGM Statement
6th Apr 200610:26 amRNSDirector/PDMR Shareholding
24th Mar 20064:17 pmRNSAdditional Listing - Replace
23rd Mar 20063:28 pmRNSAdditional Listing
16th Mar 20063:18 pmRNSDirector/PDMR Shareholding
14th Mar 20063:43 pmRNSAnnual Information Update
14th Mar 200612:26 pmRNSDirector/PDMR Shareholding
10th Mar 20067:01 amRNSFinal Results
10th Mar 20067:01 amRNSDirectorate Change
27th Feb 200611:00 amRNSNotice of Results
10th Jan 20067:00 amRNSTrading Statement
9th Dec 20054:07 pmRNSTransaction in Own Shares
14th Nov 20057:01 amRNSChange of Adviser
21st Oct 200512:28 pmRNSHolding(s) in Company
18th Oct 20058:00 amRNSTransaction in Own Shares
17th Oct 20057:00 amRNSTransaction in Own Shares
10th Oct 20054:39 pmRNSTransaction in Own Shares
30th Sep 200511:58 amRNSAcquisition of GBS-replacemt
30th Sep 20057:01 amRNSAcquisition of GBS
29th Sep 20054:00 pmRNSDirectorate Change
24th Aug 200512:18 pmRNSAdditional Listing
12th Aug 200512:58 pmRNSDirector/PDMR Shareholding
11th Aug 200511:58 amRNSAdditional Listing
11th Aug 200511:37 amRNSDirector Shareholding
9th Aug 200511:00 amRNSDirector Shareholding
29th Jul 20057:00 amRNSInterim Results
7th Jul 20057:00 amRNSNotice of Results
5th Jul 200511:00 amRNSChange of Adviser
12th May 20058:27 amRNSTransaction in Own Shares
20th Apr 20057:46 amRNSDirector Shareholding
18th Apr 20052:54 pmRNSAcquisition Completion
18th Apr 20059:32 amRNSDirector Shareholding
4th Apr 200512:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.